Delivery Order SPE2DB24D2109-SPE2DB24FHVUW

Award Date 7/9/24
Potential Completion Date 7/10/24
Potential Value $7.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of SHINGRIX VIAL KITS with a ceiling value of $5,068.44 and an ultimate completion date of May 22, 2024. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, on May 21, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation. Amerisourcebergen, a major supplier of pharmaceutical products and medical...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of SHINGRIX vial kits. The $1,104.08 award has a performance period through January 26, 2024. Amerisourcebergen Drug Corp, a for-profit organization, holds an indefinite delivery contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as...
This federal contract award was made by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp's Corporate Office Division. The $4,144.86 Firm Fixed Price delivery order contract is for the supply of SHINGRIX vial kits, a vaccine product. The contract has a period of performance through July 11, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
This federal contract award from the Defense Logistics Agency (DLA) is a delivery order valued at $1,139.18 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for SHINGRIX VIAL KITS and has a completion date of February 27, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
Amerisourcebergen Drug Corp, through its Corporate Office division, was awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide 4,563,775,114 SHINGRIX vial kits. The contract has a potential value of $16,075.81 and a completion date of February 27, 2024. This delivery order is issued under Amerisourcebergen Drug Corp's larger indefinite delivery contract (IDC) with DLA, which has a potential value of $999,999,999.00 and a...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,247.48 firm fixed-price delivery order is for the provision of SHINGRIX VIAL KITS. The contract has an ultimate completion date of June 17, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,556.72 Delivery Order contract is for the delivery of SHINGRIX VIAL KITS, a pharmaceutical product, with a performance period ending on May 14, 2025. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug...
This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide SHINGRIX vial kits. The award has a ceiling value of $15,432.01 and a period of performance through April 9, 2024. Amerisourcebergen Drug Corp is the prime contractor on this order, which falls under an Indefinite Delivery Contract (IDC) the company holds with DLA to deliver pharmaceutical products...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of SHINGRIX VIAL KITS, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $11,040.80 firm fixed-price delivery order contract has a completion date of July 15, 2024. It is not set aside for any specific business type. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, with a focus on serving the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,104.08 firm-fixed-price delivery order is for SHINGRIX vial kits, with a completion date of May 7, 2024. The award is not designated as a set-aside contract. Amerisourcebergen is a major pharmaceutical distribution company that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range...
  • SPE2DB24D2109
    Indefinite Delivery Contract
  • SPE2DB24D2109-SPE2DB24FHVUW
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of SHINGRIX vial kits to the Defense Logistics Agency (DLA), a defense agency. The firm-fixed-price delivery order, valued at $7,450.70, has a completion date of July 10, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025, to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation.

Generated 10/8/24, 9:24 AM